David C. Hanley sold $1.4M of Nuvation Bio (NUVB)

Executed Nov 19 2025, disclosed Nov 21 2025, 2 days later.

Value, as filed

$1.4M

200,000 sh × $7.14

Executed

Nov 19 2025

the trade date, as filed

Disclosed

Nov 21 2025

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

DH David C. Hanley CHIEF TECHNICAL OPERATIONS profile →

David C. Hanley (CHIEF TECHNICAL OPERATIONS) filed 1 Form 4 report in the trailing twelve months (0 purchases, 1 sale), most often in Nuvation Bio Inc. (NUVB). The largest single filing was $1.4M of NUVB (200,000 sh × $7.14, as filed), executed Nov 19 2025.

The name

NUVB Nuvation Bio Inc. NUVB · Healthcare · 18 filings in 24 months ticker →

Healthcare · Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on developing product candidates for cancer treatment

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→